The intrarenal distribution of aztreonam in healthy and diseased kidneys: Clinical therapeutic implications

A. J S Watson, R. L. Stout, A. Whelton

Research output: Contribution to journalArticlepeer-review

Abstract

Using a healthy canine model, we evaluated the influence of renal physiological activity on the stability, intrarenal distribution, and clearance of aztreonam and compared the results with the concentrations of aztreonam that can be achieved in the scarred devitalized renal tissues of patients with end-stage kidney disease. Renal physiological activity significantly modulates the intrarenal distribution of aztreonam. During the production of maximally acid-concentrated urine, urinary aztreonam levels, clearance rates, and inner zone renal tissue concentrations are increased. Aztreonam concentrations in the parenchyma of severely diseased kidneys are significantly reduced in comparison with healthy tissues; nonetheless, the values are similar to concurrent serum drug levels, a result suggesting that treatment may provide adequate coverage for aztreonam-susceptible organisms.

Original languageEnglish (US)
Pages (from-to)631-635
Number of pages5
JournalJournal of Infectious Diseases
Volume150
Issue number5
StatePublished - 1984

ASJC Scopus subject areas

  • Immunology
  • Public Health, Environmental and Occupational Health

Fingerprint

Dive into the research topics of 'The intrarenal distribution of aztreonam in healthy and diseased kidneys: Clinical therapeutic implications'. Together they form a unique fingerprint.

Cite this